FRM
JAZZ icon

Fox Run Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Fox Run Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$287K Buy
+1,567
New +$274K 0.05% 633
2025
Q4 		– Sell
-10,358
Closed -$1.37M – 1075
2025
Q3 		$1.37M Buy
+10,358
New +$1.24M 0.21% 112
2025
Q2 		– Sell
-10,339
Closed -$1.28M – 1039
2025
Q1 		$1.28M Buy
10,339
+5,918
+134% +$772K 0.2% 125
2024
Q4 		$544K Buy
+4,421
New +$521K 0.1% 410
2024
Q3 		– Sell
-12,766
Closed -$1.36M – 952
2024
Q2 		$1.36M Buy
12,766
+8,393
+192% +$923K 0.26% 92
2024
Q1 		$527K Sell
4,373
-2,068
-32% -$253K 0.11% 355
2023
Q4 		$792K Buy
+6,441
New +$804K 0.2% 152
2023
Q3 		– Sell
-3,953
Closed -$490K – 843
2023
Q2 		$490K Buy
3,953
+471
+14% +$63.4K 0.14% 290
2023
Q1 		$510K Buy
+3,482
New +$515K 0.17% 213
2020
Q1 		– Sell
-1,388
Closed -$207K – 248
2019
Q4 		$207K Buy
+1,388
New +$189K 0.17% 319
2019
Q1 		– Sell
-1,771
Closed -$220K – 578
2018
Q4 		$220K Buy
+1,771
New +$263K 0.12% 376
2018
Q1 		– Sell
-1,874
Closed -$252K – 812
2017
Q4 		$252K Buy
1,874
+74
+4% +$10.3K 0.07% 515
2017
Q3 		$263K Buy
+1,800
New +$272K 0.07% 534

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Fox Run Management's JAZZ Position: Q1 2026 in Review

Fox Run Management opened a new position in Jazz Pharmaceuticals (JAZZ) in Q1 2026: 1,567 shares worth $287K. The stake represents 0.05% of the portfolio and ranks #633 among its holdings. This is a return to the name: Fox Run Management previously reported a position in JAZZ as recently as Q3 2025.

Fox Run Management first reported a position in JAZZ in Q3 2017 and has held it in 13 quarters since. The position peaked at $1.37M in Q3 2025. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Fox Run Management held 1,567 shares of Jazz Pharmaceuticals worth $287K as of Q1 2026.
  • Jazz Pharmaceuticals was a new Fox Run Management position in Q1 2026.
  • Jazz Pharmaceuticals made up 0.05% of Fox Run Management's portfolio in Q1 2026, its #633 holding.
  • Fox Run Management first reported a position in Jazz Pharmaceuticals in Q3 2017 and has held it in 13 quarters since.
  • Fox Run Management's Jazz Pharmaceuticals position peaked at $1.37M in Q3 2025.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Fox Run Management's 13F filing for Q1 2026, filed 12 May 2026.